10/10/2019
3:02 PM | ArrowMark Colorado Holdings LLC (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A
| |
08/02/2019
4:59 PM | MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2019
4:16 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2019
3:24 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2019
3:20 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2019
3:15 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2019
3:46 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2019
4:09 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/10/2019
12:50 PM | STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A
| |
04/05/2019
3:40 PM | Viking Therapeutics (Filer)
| Form DEFA14A
| |
04/05/2019
3:25 PM | Viking Therapeutics (Filer)
| Form DEF 14A
| |
03/13/2019
5:54 PM | Viking Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2019
4:01 PM | Viking Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2019
3:12 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2019
6:53 AM | ArrowMark Colorado Holdings LLC (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G
| |
02/13/2019
11:08 AM | FMR LLC (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A
| |
02/13/2019
9:19 AM | STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G
| |
01/22/2019
6:13 PM | MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2019
6:13 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
7:35 PM | MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
7:33 PM | Masamune Hiroko (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
7:31 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
7:28 PM | Viking Therapeutics (Issuer)
Webster Stephen W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
7:27 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
7:26 PM | FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
7:22 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
7:20 PM | Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2018
4:03 PM | LIGAND PHARMACEUTICALS INC (Filed by)
Viking Therapeutics (Subject)
| Form SC 13D/A
| |
11/07/2018
4:01 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2018
9:04 AM | FMR LLC (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G
| |
09/27/2018
8:25 PM | LIGAND PHARMACEUTICALS INC (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/21/2018
3:16 PM | Viking Therapeutics (Filer)
| Form 424B5
| |
09/21/2018
5:05 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2018
3:27 PM | Viking Therapeutics (Filer)
| Form 424B5
| |
09/18/2018
6:10 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2018
4:11 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2018
11:15 PM | Viking Therapeutics (Filer)
| Form EFFECT
| |
07/11/2018
4:02 PM | Viking Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/03/2018
4:25 PM | Masamune Hiroko (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2018
4:22 PM | Masamune Hiroko (Reporting)
Viking Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/12/2018
6:10 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2018
4:13 PM | Viking Therapeutics (Filer)
| Form 424B5
| |
06/07/2018
12:41 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2018
8:04 AM | Viking Therapeutics (Filer)
| Form S-3MEF
| |
06/06/2018
3:11 PM | Viking Therapeutics (Filer)
| Form 424B5
| |
05/31/2018
6:04 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2018
6:03 PM | MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2018
6:02 PM | Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2018
5:59 PM | Viking Therapeutics (Issuer)
Webster Stephen W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2018
5:57 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2018
4:02 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2018
7:37 PM | MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2018
7:37 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/06/2018
3:38 PM | Viking Therapeutics (Filer)
| Form DEFA14A
| |
04/06/2018
3:15 PM | Viking Therapeutics (Filer)
| Form DEF 14A
| |
03/07/2018
4:16 PM | Viking Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2018
4:11 PM | Viking Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2018
3:14 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2018
3:15 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2018
8:30 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2018
3:17 PM | Viking Therapeutics (Filer)
| Form 424B5
| |
01/23/2018
4:42 PM | MORNEAU MICHAEL (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2018
4:41 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2018
11:15 PM | Viking Therapeutics (Filer)
| Form EFFECT
| |
01/16/2018
4:17 PM | Viking Therapeutics (Filer)
| Form 424B3
| |
01/09/2018
4:28 PM | Viking Therapeutics (Filer)
| Form S-1/A
| |
12/20/2017
4:21 PM | Viking Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/19/2017
1:23 PM | Farwell Grosvenor Nicholas (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G
| |
12/18/2017
8:56 AM | SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G
| |
12/11/2017
3:25 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2017
3:38 PM | Viking Therapeutics (Filer)
| Form 424B5
| |
12/06/2017
8:16 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
